{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T01:52:50Z","timestamp":1792979570401,"version":"4.5.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2013,9,29]],"date-time":"2013-09-29T00:00:00Z","timestamp":1380412800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2013,9,29]],"date-time":"2013-09-29T00:00:00Z","timestamp":1380412800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Immunol"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1038\/ni.2714","type":"journal-article","created":{"date-parts":[[2013,9,29]],"date-time":"2013-09-29T14:58:14Z","timestamp":1380466694000},"page":"1173-1182","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":650,"title":["Hypoxia-inducible factors enhance the effector responses of CD8+ T cells to persistent antigen"],"prefix":"10.1038","volume":"14","author":[{"given":"Andrew L","family":"Doedens","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony T","family":"Phan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin H","family":"Stradner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica K","family":"Fujimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica V","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randall S","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ananda W","family":"Goldrath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,9,29]]},"reference":[{"key":"BFni2714_CR1","doi-asserted-by":"publisher","first-page":"2333","DOI":"10.1128\/IAI.01515-07","volume":"76","author":"LE Via","year":"2008","unstructured":"Via, L.E. et al. Tuberculous granulomas are hypoxic in guinea pigs, rabbits, and nonhuman primates. Infect. Immun. 76, 2333\u20132340 (2008).","journal-title":"Infect. Immun."},{"key":"BFni2714_CR2","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/0026-2862(77)90106-6","volume":"13","author":"P Vaupel","year":"1977","unstructured":"Vaupel, P. Hypoxia in neoplastic tissue. Microvasc. Res. 13, 399\u2013408 (1977).","journal-title":"Microvasc. Res."},{"key":"BFni2714_CR3","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1056\/NEJMra0910283","volume":"364","author":"HK Eltzschig","year":"2011","unstructured":"Eltzschig, H.K. & Carmeliet, P. Hypoxia and inflammation. N. Engl. J. Med. 364, 656\u2013665 (2011).","journal-title":"N. Engl. J. Med."},{"key":"BFni2714_CR4","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1038\/cdd.2008.21","volume":"15","author":"EB Rankin","year":"2008","unstructured":"Rankin, E.B. & Giaccia, A.J. The role of hypoxia-inducible factors in tumorigenesis. Cell Death Differ. 15, 678\u2013685 (2008).","journal-title":"Cell Death Differ."},{"key":"BFni2714_CR5","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1126\/science.8493574","volume":"260","author":"F Latif","year":"1993","unstructured":"Latif, F. et al. Identification of the von Hippel-Lindau disease tumor suppressor gene. Science 260, 1317\u20131320 (1993).","journal-title":"Science"},{"key":"BFni2714_CR6","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.1101\/gad.14.16.1983","volume":"14","author":"GL Semenza","year":"2000","unstructured":"Semenza, G.L. HIF-1 and human disease: one highly involved factor. Genes Dev. 14, 1983\u20131991 (2000).","journal-title":"Genes Dev."},{"key":"BFni2714_CR7","doi-asserted-by":"publisher","first-page":"7592","DOI":"10.4049\/jimmunol.174.12.7592","volume":"174","author":"H Nakamura","year":"2005","unstructured":"Nakamura, H. et al. TCR engagement increases hypoxia-inducible factor-1\u03b1 protein synthesis via rapamycin-sensitive pathway under hypoxic conditions in human peripheral T cells. J. Immunol. 174, 7592\u20137599 (2005).","journal-title":"J. Immunol."},{"key":"BFni2714_CR8","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1182\/blood-2003-07-2427","volume":"103","author":"CC Blouin","year":"2004","unstructured":"Blouin, C.C., Page, E.L., Soucy, G.M. & Richard, D.E. Hypoxic gene activation by lipopolysaccharide in macrophages: implication of hypoxia-inducible factor 1\u03b1. Blood 103, 1124\u20131130 (2004).","journal-title":"Blood"},{"key":"BFni2714_CR9","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1101\/gad.1881410","volume":"24","author":"N Takeda","year":"2010","unstructured":"Takeda, N. et al. Differential activation and antagonistic function of HIF-\u03b1 isoforms in macrophages are essential for NO homeostasis. Genes Dev. 24, 491\u2013501 (2010).","journal-title":"Genes Dev."},{"key":"BFni2714_CR10","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/S0092-8674(03)00154-5","volume":"112","author":"T Cramer","year":"2003","unstructured":"Cramer, T. et al. HIF-1\u03b1 is essential for myeloid cell-mediated inflammation. Cell 112, 645\u2013657 (2003).","journal-title":"Cell"},{"key":"BFni2714_CR11","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1016\/j.cell.2011.07.033","volume":"146","author":"EV Dang","year":"2011","unstructured":"Dang, E.V. et al. Control of TH17\/Treg balance by hypoxia-inducible factor 1. Cell 146, 772\u2013784 (2011).","journal-title":"Cell"},{"key":"BFni2714_CR12","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1084\/jem.20110278","volume":"208","author":"LZ Shi","year":"2011","unstructured":"Shi, L.Z. et al. HIF1alpha-dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cells. J. Exp. Med. 208, 1367\u20131376 (2011).","journal-title":"J. Exp. Med."},{"key":"BFni2714_CR13","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1007\/s12026-012-8349-8","volume":"55","author":"EN McNamee","year":"2013","unstructured":"McNamee, E.N., Korns Johnson, D., Homann, D. & Clambey, E.T. Hypoxia and hypoxia-inducible factors as regulators of T cell development, differentiation, and function. Immunol. Res. 55, 58\u201370 (2013).","journal-title":"Immunol. Res."},{"key":"BFni2714_CR14","doi-asserted-by":"publisher","first-page":"2441","DOI":"10.1084\/jem.20112607","volume":"209","author":"DK Finlay","year":"2012","unstructured":"Finlay, D.K. et al. PDK1 regulation of mTOR and hypoxia-inducible factor 1 integrate metabolism and migration of CD8+ T cells. J. Exp. Med. 209, 2441\u20132453 (2012).","journal-title":"J. Exp. Med."},{"key":"BFni2714_CR15","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1146\/annurev.immunol.18.1.275","volume":"18","author":"JT Harty","year":"2000","unstructured":"Harty, J.T., Tvinnereim, A.R. & White, D.W. CD8+ T cell effector mechanisms in resistance to infection. Annu. Rev. Immunol. 18, 275\u2013308 (2000).","journal-title":"Annu. Rev. Immunol."},{"key":"BFni2714_CR16","doi-asserted-by":"publisher","first-page":"2485","DOI":"10.1084\/jem.20121015","volume":"209","author":"H Frebel","year":"2012","unstructured":"Frebel, H. et al. Programmed death 1 protects from fatal circulatory failure during systemic virus infection of mice. J. Exp. Med. 209, 2485\u20132499 (2012).","journal-title":"J. Exp. Med."},{"key":"BFni2714_CR17","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.cell.2009.06.036","volume":"138","author":"HW Virgin","year":"2009","unstructured":"Virgin, H.W., Wherry, E.J. & Ahmed, R. Redefining chronic viral infection. Cell 138, 30\u201350 (2009).","journal-title":"Cell"},{"key":"BFni2714_CR18","doi-asserted-by":"publisher","first-page":"7875","DOI":"10.1073\/pnas.1003345107","volume":"107","author":"J Matsuzaki","year":"2010","unstructured":"Matsuzaki, J. et al. Tumor-infiltrating NY-ESO-1-specific CD8+ T cells are negatively regulated by LAG-3 and PD-1 in human ovarian cancer. Proc. Natl. Acad. Sci. USA 107, 7875\u20137880 (2010).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFni2714_CR19","doi-asserted-by":"publisher","first-page":"2350","DOI":"10.1172\/JCI46102","volume":"121","author":"L Baitsch","year":"2011","unstructured":"Baitsch, L. et al. Exhaustion of tumor-specific CD8+ T cells in metastases from melanoma patients. J. Clin. Invest. 121, 2350\u20132360 (2011).","journal-title":"J. Clin. Invest."},{"key":"BFni2714_CR20","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/ni.2035","volume":"12","author":"EJ Wherry","year":"2011","unstructured":"Wherry, E.J. T cell exhaustion. Nat. Immunol. 12, 492\u2013499 (2011).","journal-title":"Nat. Immunol."},{"key":"BFni2714_CR21","doi-asserted-by":"publisher","first-page":"9038","DOI":"10.1128\/MCB.24.20.9038-9047.2004","volume":"24","author":"MP Biju","year":"2004","unstructured":"Biju, M.P. et al. Vhlh gene deletion induces Hif-1-mediated cell death in thymocytes. Mol. Cell Biol. 24, 9038\u20139047 (2004).","journal-title":"Mol. Cell Biol."},{"key":"BFni2714_CR22","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1073\/pnas.98.4.1583","volume":"98","author":"VH Haase","year":"2001","unstructured":"Haase, V.H., Glickman, J.N., Socolovsky, M. & Jaenisch, R. Vascular tumors in livers with targeted inactivation of the von Hippel-Lindau tumor suppressor. Proc. Natl. Acad. Sci. USA 98, 1583\u20131588 (2001).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFni2714_CR23","doi-asserted-by":"publisher","first-page":"6725","DOI":"10.4049\/jimmunol.174.11.6725","volume":"174","author":"DJ Zhang","year":"2005","unstructured":"Zhang, D.J. et al. Selective expression of the Cre recombinase in late-stage thymocytes using the distal promoter of the Lck gene. J. Immunol. 174, 6725\u20136731 (2005).","journal-title":"J. Immunol."},{"key":"BFni2714_CR24","doi-asserted-by":"publisher","first-page":"2301","DOI":"10.1073\/pnas.0608382104","volume":"104","author":"M Gruber","year":"2007","unstructured":"Gruber, M. et al. Acute postnatal ablation of Hif-2\u03b1 results in anemia. Proc. Natl. Acad. Sci. USA 104, 2301\u20132306 (2007).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFni2714_CR25","doi-asserted-by":"publisher","first-page":"3005","DOI":"10.1093\/emboj\/17.11.3005","volume":"17","author":"HE Ryan","year":"1998","unstructured":"Ryan, H.E., Lo, J. & Johnson, R.S. HIF-1 alpha is required for solid tumor formation and embryonic vascularization. EMBO J. 17, 3005\u20133015 (1998).","journal-title":"EMBO J."},{"key":"BFni2714_CR26","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/j.immuni.2007.09.006","volume":"27","author":"EJ Wherry","year":"2007","unstructured":"Wherry, E.J. et al. Molecular signature of CD8+ T cell exhaustion during chronic viral infection. Immunity 27, 670\u2013684 (2007).","journal-title":"Immunity"},{"key":"BFni2714_CR27","doi-asserted-by":"publisher","first-page":"4911","DOI":"10.1128\/JVI.77.8.4911-4927.2003","volume":"77","author":"EJ Wherry","year":"2003","unstructured":"Wherry, E.J., Blattman, J.N., Murali-Krishna, K., van der Most, R. & Ahmed, R. Viral persistence alters CD8 T-cell immunodominance and tissue distribution and results in distinct stages of functional impairment. J. Virol. 77, 4911\u20134927 (2003).","journal-title":"J. Virol."},{"key":"BFni2714_CR28","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.immuni.2007.07.010","volume":"27","author":"NS Joshi","year":"2007","unstructured":"Joshi, N.S. et al. Inflammation directs memory precursor and short-lived effector CD8(+) T cell fates via the graded expression of T-bet transcription factor. Immunity 27, 281\u2013295 (2007).","journal-title":"Immunity"},{"key":"BFni2714_CR29","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1038\/ni1009","volume":"4","author":"SM Kaech","year":"2003","unstructured":"Kaech, S.M. et al. Selective expression of the interleukin 7 receptor identifies effector CD8 T cells that give rise to long-lived memory cells. Nat. Immunol. 4, 1191\u20131198 (2003).","journal-title":"Nat. Immunol."},{"key":"BFni2714_CR30","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/j.immuni.2009.11.007","volume":"31","author":"SC Jameson","year":"2009","unstructured":"Jameson, S.C. & Masopust, D. Diversity in T cell memory: an embarrassment of riches. Immunity 31, 859\u2013871 (2009).","journal-title":"Immunity"},{"key":"BFni2714_CR31","doi-asserted-by":"publisher","first-page":"4661","DOI":"10.4049\/jimmunol.172.8.4661","volume":"172","author":"KA Frauwirth","year":"2004","unstructured":"Frauwirth, K.A. & Thompson, C.B. Regulation of T lymphocyte metabolism. J. Immunol. 172, 4661\u20134665 (2004).","journal-title":"J. Immunol."},{"key":"BFni2714_CR32","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1146\/annurev-immunol-032712-095956","volume":"31","author":"NJ MacIver","year":"2013","unstructured":"MacIver, N.J., Michalek, R.D. & Rathmell, J.C. Metabolic regulation of T lymphocytes. Annu. Rev. Immunol. 31, 259\u2013283 (2013).","journal-title":"Annu. Rev. Immunol."},{"key":"BFni2714_CR33","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1126\/science.1229620","volume":"338","author":"MA Paley","year":"2012","unstructured":"Paley, M.A. et al. Progenitor and terminal subsets of CD8+ T cells cooperate to contain chronic viral infection. Science 338, 1220\u20131225 (2012).","journal-title":"Science"},{"key":"BFni2714_CR34","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/0092-8674(89)90573-4","volume":"56","author":"MB Oldstone","year":"1989","unstructured":"Oldstone, M.B. Viral persistence. Cell 56, 517\u2013520 (1989).","journal-title":"Cell"},{"key":"BFni2714_CR35","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1126\/science.1214935","volume":"335","author":"R Medzhitov","year":"2012","unstructured":"Medzhitov, R., Schneider, D.S. & Soares, M.P. Disease tolerance as a defense strategy. Science 335, 936\u2013941 (2012).","journal-title":"Science"},{"key":"BFni2714_CR36","doi-asserted-by":"publisher","first-page":"e1000313","DOI":"10.1371\/journal.ppat.1000313","volume":"5","author":"N Nakamoto","year":"2009","unstructured":"Nakamoto, N. et al. Synergistic reversal of intrahepatic HCV-specific CD8 T cell exhaustion by combined PD-1\/CTLA-4 blockade. PLoS Pathog. 5, e1000313 (2009).","journal-title":"PLoS Pathog."},{"key":"BFni2714_CR37","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/ni.1679","volume":"10","author":"SD Blackburn","year":"2009","unstructured":"Blackburn, S.D. et al. Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection. Nat. Immunol. 10, 29\u201337 (2009).","journal-title":"Nat. Immunol."},{"key":"BFni2714_CR38","doi-asserted-by":"publisher","first-page":"14733","DOI":"10.1073\/pnas.1009731107","volume":"107","author":"HT Jin","year":"2010","unstructured":"Jin, H.T. et al. Cooperation of Tim-3 and PD-1 in CD8 T-cell exhaustion during chronic viral infection. Proc. Natl. Acad. Sci. USA 107, 14733\u201314738 (2010).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFni2714_CR39","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1111\/j.1600-065X.2011.01063.x","volume":"244","author":"LM Snell","year":"2011","unstructured":"Snell, L.M., Lin, G.H., McPherson, A.J., Moraes, T.J. & Watts, T.H. T-cell intrinsic effects of GITR and 4\u20131BB during viral infection and cancer immunotherapy. Immunol. Rev. 244, 197\u2013217 (2011).","journal-title":"Immunol. Rev."},{"key":"BFni2714_CR40","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.immuni.2009.08.005","volume":"31","author":"RM Welsh","year":"2009","unstructured":"Welsh, R.M. Blimp hovers over T cell immunity. Immunity 31, 178\u2013180 (2009).","journal-title":"Immunity"},{"key":"BFni2714_CR41","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1126\/science.1159806","volume":"321","author":"AM Intlekofer","year":"2008","unstructured":"Intlekofer, A.M. et al. Anomalous type 17 response to viral infection by CD8+ T cells lacking T-bet and eomesodermin. Science 321, 408\u2013411 (2008).","journal-title":"Science"},{"key":"BFni2714_CR42","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/nrc885","volume":"2","author":"WG Kaelin Jr.","year":"2002","unstructured":"Kaelin, W.G. Jr. Molecular basis of the VHL hereditary cancer syndrome. Nat. Rev. Cancer 2, 673\u2013682 (2002).","journal-title":"Nat. Rev. Cancer"},{"key":"BFni2714_CR43","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1038\/ng1019","volume":"32","author":"SO Ang","year":"2002","unstructured":"Ang, S.O. et al. Disruption of oxygen homeostasis underlies congenital Chuvash polycythemia. Nat. Genet. 32, 614\u2013621 (2002).","journal-title":"Nat. Genet."},{"key":"BFni2714_CR44","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.3324\/haematol.2011.045609","volume":"96","author":"GY Miasnikova","year":"2011","unstructured":"Miasnikova, G.Y. et al. The heterozygote advantage of the Chuvash polycythemia VHLR200W mutation may be protection against anemia. Haematologica 96, 1371\u20131374 (2011).","journal-title":"Haematologica"},{"key":"BFni2714_CR45","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1002\/ajh.21327","volume":"84","author":"X Niu","year":"2009","unstructured":"Niu, X. et al. Altered cytokine profiles in patients with Chuvash polycythemia. Am. J. Hematol. 84, 74\u201378 (2009).","journal-title":"Am. J. Hematol."},{"key":"BFni2714_CR46","doi-asserted-by":"publisher","first-page":"560","DOI":"10.3324\/haematol.2012.070508","volume":"98","author":"NL Tomasic","year":"2013","unstructured":"Tomasic, N.L. et al. The phenotype of polycythemia due to Croatian homozygous VHL (571C>G:H191D) mutation is different from that of Chuvash polycythemia (VHL 598C>T:R200W). Haematologica 98, 560\u2013567 (2013).","journal-title":"Haematologica"},{"key":"BFni2714_CR47","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1038\/nature04444","volume":"439","author":"DL Barber","year":"2006","unstructured":"Barber, D.L. et al. Restoring function in exhausted CD8 T cells during chronic viral infection. Nature 439, 682\u2013687 (2006).","journal-title":"Nature"},{"key":"BFni2714_CR48","doi-asserted-by":"publisher","first-page":"7465","DOI":"10.1158\/0008-5472.CAN-10-1439","volume":"70","author":"AL Doedens","year":"2010","unstructured":"Doedens, A.L. et al. Macrophage expression of hypoxia-inducible factor-1\u03b1 suppresses T-cell function and promotes tumor progression. Cancer Res. 70, 7465\u20137475 (2010).","journal-title":"Cancer Res."},{"key":"BFni2714_CR49","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/S1074-7613(01)00227-8","volume":"15","author":"PP Lee","year":"2001","unstructured":"Lee, P.P. et al. A critical role for Dnmt1 and DNA methylation in T cell development, function, and survival. Immunity 15, 763\u2013774 (2001).","journal-title":"Immunity"},{"key":"BFni2714_CR50","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/342559a0","volume":"342","author":"H Pircher","year":"1989","unstructured":"Pircher, H., Burki, K., Lang, R., Hengartner, H. & Zinkernagel, R.M. Tolerance induction in double specific T-cell receptor transgenic mice varies with antigen. Nature 342, 559\u2013561 (1989).","journal-title":"Nature"}],"container-title":["Nature Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/ni.2714.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/ni.2714","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/ni.2714.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,16]],"date-time":"2022-04-16T05:03:50Z","timestamp":1650085430000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ni.2714"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9,29]]},"references-count":50,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["BFni2714"],"URL":"https:\/\/doi.org\/10.1038\/ni.2714","relation":{},"ISSN":["1529-2908","1529-2916"],"issn-type":[{"value":"1529-2908","type":"print"},{"value":"1529-2916","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,9,29]]},"assertion":[{"value":"17 July 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2013","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2013","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A.L.D., A.T.P., R.S.J. and A.W.G. hold a provisional patent for manipulation of the VHL-HIF pathway for therapy.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}